Evidence map›Paper›PMID 32303525›Full record

ArticleBMJ case reports2020

Mark Anthony Diaz, Maria Luisa Bayo, Francisco Alvarez, Salvador Alvarez

Open access · greenAbstract readCase Reports
In one paragraph

Article in BMJ case reports, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.3field-weighted citation impact, top 41% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 3 citations in OpenAlex.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 3 institutions in 2 countries.

Mark Anthony DiazDivision of Infectious Diseases, Mayo Clinic, Jacksonville, Florida, USA.
Maria Luisa BayoUniversity of Navarra, Pamplona, Navarra, Spain.
Francisco AlvarezDivision of Infectious Diseases, Mayo Clinic, Jacksonville, Florida, USA.
Salvador AlvarezDivision of Infectious Diseases, Mayo Clinic, Jacksonville, Florida, USA salvarez@mayo.edu.
WinnMed · USOffice of Infectious Diseases · USUniversidad de Navarra · ES

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

A middle-aged woman was hospitalised for generalised, painful skin lesions 6 weeks after a successful double-lung transplant. She had end-stage lung disease associated with chronic obstructive pulmonary disease due to alpha-1 antitrypsin deficiency, and she had been treated with itraconazole for 16 months because of lung infection associated with

Indexed as

Lung TransplantationAntifungal AgentsCoccidioidomycosisDermatomycosesFemaleHumansImmunocompromised HostMiddle AgedTriazolesAntifungal AgentsposaconazoleTriazolesdermatologyinfectious diseasestransplantation

Identifiers

PMID32303525
PMCPMC7199097
OpenAlexW3016992405

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.